Projects per year
Personal profile
Education
B.S., Chang Gung University,Taiwan
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Ping-Chih Hsu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
Using Lung Cancer Patient-Derived Xenograft (Pdx) to Explore the Interaction between Yap Signaling Pathway and Cyclin-Dependent Kinases (Cdk) and New Therapeutic Target for Lung Cancer
Hsu, P.-C. (PI)
01/08/23 → 31/07/24
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
The Role of Yes-Associated Protein (Yap) and Cyclin-Dependent Kinase 9 (Cdk9) in Regulating Lung Cancer Brain Metastasis and Application of Lung Cancer Patient-Derived Xenograft (Pdx) Mice Model to Develop Novel Treatment (To Continue 2019 Most).( III )
Hsu, P.-C. (PI)
01/08/22 → 31/07/23
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC
Tung, P. H., Chiu, T. H., Huang, A. C. C., Ju, J. S., Huang, C. H., Wang, C. C., Ko, H. W., Chung, F. T., Hsu, P. C., Fang, Y. F., Guo, Y. K., Kuo, C. H. S. & Yang, C. T., 01 01 2024, In: Therapeutic Advances in Medical Oncology. 16, p. 17588359231222604Research output: Contribution to journal › Journal Article › peer-review
Open Access -
Effectiveness and safety of afatinib, gefitinib, and erlotinib for treatment-naïve elderly patients with epidermal growth factor receptor-mutated advanced non-small-cell lung cancer: a multiinstitute retrospective study
Hung, L. J., Hsu, P. C., Yang, C.-T., Kuo, C. H. S., Chang, J. W. C., Huang, C. Y., Chang, C. F. & Wu, C. E., 08 01 2024, In: Aging. 16, 1, p. 550-567 18 p.Research output: Contribution to journal › Journal Article › peer-review
Open Access1 Scopus citations -
Effectiveness and safety of afatinib, gefitinib, and erlotinib for treatment-naïve elderly patients with epidermal growth factor receptor-mutated advanced non-small-cell lung cancer: a multi-institute retrospective study
Wu, C.-E., Chang, J.W.-C., Hsu, P.-C., Yang, C.-T., 黃振洋, 郭志熙, 張境夫 & 洪淩真, 01 2024, In: Aging. 16, 1, p. 550 - 567Research output: Contribution to journal › Journal Article › peer-review
-
Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer
Chiu, L. C., Hsu, P. C., Wang, C. C., Ko, H. W., Kuo, S. C. H., Ju, J. S., Tung, P. H., Huang, A. C. C. & Yang, C.-T., 03 2024, In: Thoracic Cancer. 15, 7, p. 529-537 9 p.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study
Chiu, L. C., Lee, C. S., Hsu, P. C., Li, H. H., Chan, T. M., Hsiao, C. C., Kuo, S. C. H., Ko, H. W., Lin, S. M., Wang, C. H., Lin, H. C., Chu, P. H. & Yen, T. H., 19 03 2024, In: Environmental Health: A Global Access Science Source. 23, 1, p. 29 29.Research output: Contribution to journal › Journal Article › peer-review
Open Access1 Scopus citations